Načítá se...
Treatment of Mild, Moderate, and Severe Lupus Erythematosus: Focus on New therapies
Despite large-scale efforts devoted to the conduct of clinical trials in systemic lupus erythematosus (SLE), there has been no new therapy approved for this disease in over fifty years. Increased understanding of the immunologic mechanisms underlying SLE has led to the development of a variety of bi...
Uloženo v:
| Vydáno v: | Curr Rheumatol Rep |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4400849/ https://ncbi.nlm.nih.gov/pubmed/21584692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11926-011-0186-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|